Nebivolol

adrenoceptor beta 1 ; Homo sapiens







46 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35198688 Data of Nebivolol on oxidative stress parameters in hypertensive patients. 2022 Apr 1
2 33064027 Nebivolol/valsartan combination for the treatment of hypertension: a review. 2021 Jul 2
3 34106365 Therapeutic Properties of Highly Selective β-blockers With or Without Additional Vasodilator Properties: Focus on Bisoprolol and Nebivolol in Patients With Cardiovascular Disease. 2021 Jun 9 1
4 34453839 Comparative beneficial effects of nebivolol and nebivolol/valsartan combination against mitochondrial dysfunction in angiotensin II-induced pathology in H9c2 cardiomyoblasts. 2021 Oct 7 1
5 28209351 An indirect stereoselective analysis of nebivolol glucuronides in plasma by LC-MS/MS: Application to clinical pharmacokinetics. 2017 Sep 10 2
6 27172427 Nebivolol has a beneficial effect in monocrotaline-induced pulmonary hypertension. 2016 Jul 1
7 25747524 Nebivolol and valsartan as a fixed-dose combination for the treatment of hypertension. 2015 Apr 2
8 26177892 A Review of Nebivolol Pharmacology and Clinical Evidence. 2015 Aug 1
9 23603323 The Nebivolol action on vascular tone is dependent on actin cytoskeleton polymerization and Rho-A activity into ECs and SMCs. 2014 1
10 23547240 Differential effects of nebivolol versus metoprolol on functional sympatholysis in hypertensive humans. 2013 Jun 1
11 21283024 Nebivolol: an endothelium-friendly selective β1-adrenoceptor blocker. 2012 Jan 2
12 21172342 Lack of evidence that nebivolol is a β₃-adrenoceptor agonist. 2011 Mar 1 1
13 20128815 The selective beta1-adrenoceptor antagonist nebivolol is a potential oestrogen receptor agonist with neuroprotective abilities. 2010 Mar 2
14 19121451 Comparison of Nebivolol monotherapy versus Nebivolol in combination with other antihypertensive therapies for the treatment of hypertension. 2009 Jan 15 1
15 19412697 [Third generation beta-blockers: current state of research on vasodilating beta-blockers]. 2009 1
16 18072266 Stereochemical comparison of nebivolol with other beta-blockers. 2008 Feb 1
17 18083889 Nebivolol: pharmacologic profile of an ultraselective, vasodilatory beta1-blocker. 2008 Feb 1
18 18786089 Nebivolol: a highly selective beta1-adrenergic receptor blocker that causes vasodilation by increasing nitric oxide. 2008 Fall 2
19 19066009 Effects of the vasodilating beta-blocker nebivolol on smoking-induced endothelial dysfunction in young healthy volunteers. 2008 1
20 17235472 Does the beta-blocker nebivolol increase coronary flow reserve? 2007 Apr 1
21 17280840 Effect of DL-nebivolol, its enantiomers and metabolites on the intracellular production of superoxide and nitric oxide in human endothelial cells. 2007 Apr 2
22 17664392 Nebivolol induces nitric oxide release in the heart through inducible nitric oxide synthase activation. 2007 Oct 1
23 17786067 A randomized, double-blind, placebo-controlled parallel-group study to assess the efficacy and safety of nebivolol, a novel beta-blocker, in patients with mild to moderate hypertension. 2007 Sep 1
24 17977009 Nebivolol reduces asymmetric dimethylarginine in endothelial cells by increasing dimethylarginine dimethylaminohydrolase 2 (DDAH2) expression and activity. 2007 Dec 1
25 16716362 ENOS is not activated by nebivolol in human failing myocardium. 2006 Aug 22 1
26 16116070 Endothelial beta3-adrenoreceptors mediate nitric oxide-dependent vasorelaxation of coronary microvessels in response to the third-generation beta-blocker nebivolol. 2005 Aug 23 1
27 16156687 Economic evaluation of nebivolol in the treatment of hypertension. 2005 1
28 16187009 Effect of nebivolol and atenolol on brachial artery flow-mediated vasodilation in patients with coronary artery disease. 2005 Aug 1
29 15071350 Estrogen receptor-mediated vascular responsiveness to nebivolol: a novel endothelium-related mechanism of therapeutic vasorelaxation. 2004 May 1
30 15492765 Pharmacological mechanisms of clinically favorable properties of a selective beta1-adrenoceptor antagonist, nebivolol. 2004 Fall 1
31 15587107 Experimental evidences of nitric oxide-dependent vasodilatory activity of nebivolol, a third-generation beta-blocker. 2004 Oct 1
32 12535855 Beta 1-adrenoceptor selectivity of nebivolol and bisoprolol. A comparison of [3H]CGP 12.177 and [125I]iodocyanopindolol binding studies. 2003 Jan 26 5
33 12692005 Nebivolol prevents vascular NOS III uncoupling in experimental hyperlipidemia and inhibits NADPH oxidase activity in inflammatory cells. 2003 Apr 1 1
34 12494141 [Effects of nebivolol on microcirculation, platelet aggregation and blood viscosity in patients with essential hypertension]. 2002 1
35 11309552 Beta-blockade with nebivolol enhances the acetylcholine-induced cutaneous vasodilation. 2001 Apr 1
36 11483868 Nebivolol induces calcium-independent signaling in endothelial cells by a possible beta-adrenergic pathway. 2001 Aug 1
37 11707696 Effects of nebivolol on human platelet aggregation. 2001 Dec 1
38 11012562 Nebivolol decreases systemic oxidative stress in healthy volunteers. 2000 Oct 1
39 9049578 Pharmacological properties of nebivolol in man. 1997 2
40 9010695 Haemodynamic effects and pharmacokinetics of oral d- and l-nebivolol in hypertensive patients. 1996 1
41 7826820 Nitric oxide mediated venodilator effects of nebivolol. 1994 Sep 1
42 7687708 Nebivolol in hypertension: a double-blind placebo-controlled multicenter study assessing its antihypertensive efficacy and impact on quality of life. 1993 Jun 1
43 8098243 Comparison of antihypertensive and beta 1-adrenoceptor antagonist effect of nebivolol and atenolol in essential hypertension. 1993 May 2
44 1353367 Exercise tolerance with nebivolol and atenolol. 1992 Jun 1
45 1681809 Human beta 1- and beta 2-adrenergic receptor binding and mediated accumulation of cAMP in transfected Chinese hamster ovary cells. Profile of nebivolol and known beta-adrenergic blockers. 1991 Oct 9 3
46 2565239 Nebivolol is devoid of intrinsic sympathomimetic activity. 1989 Jan 2 1